Please select the option that best describes you:

For path CR after neoadjuvant chemotherapy in breast cancer with sentinel node (2-3 nodes) negative but >4 nodes positive on initial PET, do you boost the nodes not assessed by sentinel node?  

Do biomarkers impact your decision-making? If you were to boost, what dose would you use?



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at University of Rochester Wilmot Cancer Institute
I have done the same as @Sushil Beriwal, and of co...
Sign in or Register to read more